Merck (MRK) is a publicly traded Healthcare sector company. As of July 14, 2026, MRK trades at $121.82 with a market cap of $305.12B and a P/E ratio of 34.64. MRK moved -0.31% today. Year to date, MRK is +16.94%; over the trailing twelve months it is +48.79%. Its 52-week range spans $73.31 to $130.29. Analyst consensus is buy with an average price target of $140.31. Rallies surfaces MRK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MRK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $121.82 |
| Market Cap | $305.12B |
| P/E Ratio | 34.64 |
| EPS | $3.57 |
| Dividend Yield | 0.85% |
| 52-Week High | $130.29 |
| 52-Week Low | $73.31 |
| Volume | 249.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $65.77B |
| Net Income | $8.93B |
| Gross Margin | 73.91% |
18 analysts cover MRK: 0 strong buy, 13 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $140.31.